GlobeNewswire Inc | May 6, 2021 08:00AM EDT

May 06, 2021

SOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc.(GBT) (NASDAQ: GBT) today announced that it will participate in virtual fireside chats at the following investor conferences:

-- Bank of America 2021 Healthcare Conference on May 12 at 4:15 p.m. ET; and -- RBC Capital Markets Global Healthcare Conference on May 19 at 3:05 p.m. ET.

The fireside chats will be webcast live from GBTs website atwww.gbt.com in the Investors section. Replays of the webcasts will be archived and available for one month following each event.

About Global Blood Therapeutics

Global Blood Therapeutics(GBT) is a biopharmaceutical company dedicated to the discovery, development, and delivery of life-changing treatments that provide hope to underserved patient communities. Founded in 2011, GBT is delivering on its goal to transform the treatment and care of sickle cell disease (SCD), a lifelong, devastating inherited blood disorder. The company has introduced Oxbryta(voxelotor) tablets, the first FDA-approved treatment that directly inhibits sickle hemoglobin polymerization, the root cause of red blood cell sickling in SCD. GBT is also advancing its pipeline program in SCD with inclacumab, a P-selectin inhibitor in development to address pain crises associated with the disease, and GBT021601 (GBT601), the companys next generation hemoglobin S polymerization inhibitor. In addition, GBTs drug discovery teams are working on new targets to develop the next wave of treatments for SCD. To learn more, please visitwww.gbt.comand follow the company on Twitter@GBT_news.

Contact:Steven Immergut (media)650-410-3258simmergut@gbt.com

Courtney Roberts(investors)650-351-7881croberts@gbt.com